Dialysis

 

Interview, Kirsty Bashforth, Chief business officer, Diaverum

Chronic Kidney Disease is a continuing to rise, further impacted by COVID and the wider economic burden. We discuss how digitalisation, improving health literacy and a more holistic approach could make a difference to the outlook in this sector with Kirsty Bashforth, chief business officer, Diaverum, ahead of her How to Build a Brand workshop at HBI 2022. 
June 10, 2022

Warsaw hub model set to spread across CEE

A new Warsaw Health Innovation Hub in Poland has seen 30 big pharma and medtech contribute brains and money to tackle healthcare projects, extending the cooperation which developed during Covid between the government and the private sector. Healthcare providers are set to join. The model is likely to be adopted by other CEE countries.
May 26, 2022

Diaverum launches holiday booking platform

Global renal care provider Diaverum is launching a digital platform for holiday dialysis booking. HBI speaks with Bruno Pamplona Polizio, director of global communications at Diaverum, to learn more.
May 5, 2022

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
March 24, 2022

Fresenius break up debate goes public

Giant health care conglomerate Fresenius SE has publicly floated the possibility of bringing minority equity shareholders in at the level of divisions such as Vamed or Helios in its 2021 results announcement. It has even suggested it could sell its controlling stake in dialysis arm Fresenius Medical Care. But at least one investment bank is publicly stating this doesn't go far enough.
February 25, 2022

Excess deaths force cost cutting at Fresenius Medical Care

Dialysis patients are dying from COVID at increasingly high rates at Fresenius Medical Care, forcing the provider to slash 5,000 jobs and target €500m cost savings annually by 2025. The group has seen 18,200 more patients die than expected since the beginning of the pandemic, representing over 5% of its total base.
November 4, 2021

Diaverum rolls out algorithm to predict thrombosis

Vascular access thrombosis is an expensive and painful complication for dialysis patients, with an incident rate of 0.11-0.5 episodes per patient per year. Global dialysis provider Diaverum has started to roll out an algorithm that can predict 75% of cases missed by current practices, enabling earlier interventions.
October 14, 2021

EMEA’s Top 100 largest groups by revenue revealed

HBI’s inaugural HBI Health Care Services Top 100 lists the largest 100 companies by EMEA health care services revenue. In total revenue their revenue came to over €105bn - and we've uncovered some surprising winners and losers. 
July 29, 2021
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us